A analyze printed in JAMA Network Open up emphasizes the discrepancy in between what it prices to provide copyright along with the retail selling prices sufferers experience. Regardless of the reduced creation expenditures, Novo Nordisk has not publicly disclosed distinct figures for copyright or its other products, Wegovy.California biotech behemo